Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars
about
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryProbing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active sitePiperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside MacrophagesStructure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversityTackling tuberculosis: Insights from an international TB Summit in LondonA GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.Recent advances in the research of heterocyclic compounds as antitubercular agents.Crystal structure of arylamine N-acetyltransferases: insights into the mechanisms of action and substrate selectivity.Arylamine N-acetyltransferases: a structural perspective.Triazole: A Promising Antitubercular Agent.Cholesterol metabolism: a potential therapeutic target in Mycobacteria.Identification of the anti-mycobacterial functional properties of piperidinol derivatives.Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition.Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis-a meeting report of a Euroscicon conference.Xenobiotic-metabolizing enzymes in Bacillus anthracis: molecular and functional analysis of a truncated arylamine N-acetyltransferase isozyme.Exploration of Piperidinols as Potential Antitubercular AgentsAntimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in : Efficacy and Safety Investigations
P2860
Q26995125-7E7DDA41-F1D5-4D8A-94DB-C7CC89934EABQ27666450-E27567BA-D6CF-43C1-BD15-F38229EFDBBDQ27675714-413A3189-D264-47A5-93AF-5ACC98B2C194Q27685295-7FD68424-33DF-451B-8B95-8E4069C943C3Q28602294-A6775A1F-2732-42D7-A137-EB03BFC78B82Q34940777-970789E2-92CF-47D3-83CD-F5E49037A295Q36057012-688DBF32-52F3-4714-A479-1C62875ACD60Q36336273-01C12FFE-6C5B-4D58-9B81-4087F02D67C4Q38050102-A7C56B97-1755-46E6-8E86-A07484351988Q38071704-65CB8067-6F60-4F22-B018-E6137FF1830BQ38091708-0BB4B387-F562-428B-BA58-D929950CFE71Q38341275-D3307F50-A6AF-48E0-8A87-4138F36750FEQ39047211-0ADA8A1E-BEB5-4FCB-9E35-7F7045505053Q40333807-23D12CDE-A8B5-4D65-A4B7-76FC6CD3DA00Q41675804-CAC0A3BA-2D28-45E1-A6D9-71C598489712Q42314991-30AC08ED-5C8A-435F-9756-446CA9F502A5Q42741549-DB70670A-ED24-494F-B94E-A15BACE69BD1Q46459828-1707D735-EE12-4B64-A420-73D42E5ACC72Q57976064-9B4533C7-B829-4ED7-985A-E1566A09D15AQ58734819-0D4183EA-7939-4213-B587-7E0C6E1FF90B
P2860
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of arylamine N- ...... towards novel anti-tuberculars
@ast
Identification of arylamine N- ...... towards novel anti-tuberculars
@en
type
label
Identification of arylamine N- ...... towards novel anti-tuberculars
@ast
Identification of arylamine N- ...... towards novel anti-tuberculars
@en
prefLabel
Identification of arylamine N- ...... towards novel anti-tuberculars
@ast
Identification of arylamine N- ...... towards novel anti-tuberculars
@en
P2093
P2860
P50
P1433
P1476
Identification of arylamine N- ...... towards novel anti-tuberculars
@en
P2093
Andrew W Mulvaney
Elizabeth Fullam
Isaac M Westwood
Matthew C Anderton
Sanjib Bhakta
Stephen G Davies
Veemal Bhowruth
P2860
P2888
P356
10.1007/S13238-010-0006-1
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1002201565